|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization of intangibles | |||||
| Asset impairments | |||||
| Gain on sale of assets | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Loss related to revolver refinancing | |||||
| Non-operating pension benefit (cost) | |||||
| Gain on sale of note receivable | |||||
| Income before taxes | |||||
| Income tax expense | |||||
| Income from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Loss from disposal of discontinued operations, net of tax | |||||
| Net income | |||||
| Less: Net loss attributable to noncontrolling interest | |||||
| Net income attributable to Belden common stockholders | |||||
| Weighted average number of common shares and equivalents: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Continuing operations (in dollars per share) | |||||
| Discontinued operations (in dollars per share) | |||||
| Disposal of discontinued operations (in dollars per share) | |||||
| Basic income per share attributable to Belden common stockholders (in dollars per share) | |||||
| Continuing operation (in dollars per share) | |||||
| Diluted income per share attributable to Belden common stockholders (in dollars per share) | |||||
Loading...
